Si prevede che il mercato degli antibiotici a base di carbapenemi crescerà da 3.964,57 milioni di dollari nel 2021 a 5.346,62 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 4,4% nel periodo 2021-2028.
I carbapenemi sono un tipo di antibiotici β-lattamici atipici che hanno un'attività antibatterica più ampia. Gli antibiotici a base di carbapenemi possono coprire molti batteri gram-positivi, gram-negativi, aerobici e anaerobici. Inoltre, gli antibiotici a base di carbapenemi sono stabili alla maggior parte delle β-lattamasi. Quindi, sono indicati come monoterapia empirica per varie condizioni gravi, come infezioni neutropeniche e infezioni intra-addominali.
La crescente prevalenza di infezioni batteriche gram-negative e la crescente produzione di farmaci generici alimentano la crescita del mercato degli antibiotici a base di carbapenemi . Tuttavia, il noioso e costoso processo di sviluppo degli antibiotici frena la crescita del mercato.
Personalizza questo report in base alle tue esigenze
Riceverai la personalizzazione gratuita di qualsiasi report, comprese parti di questo report, o analisi a livello nazionale, pacchetto dati Excel, oltre a usufruire di grandi offerte e sconti per start-up e università
Mercato degli antibiotici a base di carbapenemi: approfondimenti strategici
- Scopri le principali tendenze di mercato in questo rapporto.Questo campione GRATUITO includerà analisi di dati che spaziano dalle tendenze di mercato alle stime e alle previsioni.
Approfondimenti di mercato
Aumento della prevalenza delle infezioni batteriche Gram-negative
Le infezioni batteriche Gram-negative, come infezioni del tratto urinario (UTI), polmonite, infezioni del flusso sanguigno, infezioni delle ferite o del sito chirurgico e meningite, vengono comunemente contratte dai pazienti durante la degenza ospedaliera. Queste infezioni sono generalmente note come infezioni acquisite in ospedale (HAI). Infezioni come UTI e polmonite sono comuni nei pazienti ricoverati in unità di terapia intensiva. Secondo l'US National Healthcare Safety Network, il 30% delle HAI è causato da batteri gram-negativi, circa il 45% è dovuto a UTI e circa il 47% è dovuto a polmonite associata alla ventilazione (VAP). La prevalenza di malattie infettive causate da batteri gram-negativi è in rapido aumento.
Inoltre, le infezioni batteriche gram-negative sono resistenti a più farmaci e hanno sviluppato una migliore resistenza agli antibiotici disponibili. La resistenza antimicrobica (AMR) è diventata una minaccia globale per la medicina moderna. Pertanto, è necessario un monitoraggio costante delle tendenze emergenti per gli isolati clinici. Un gruppo di ricercatori in Lettonia, Europa, ha studiato la progressione dell'AMR per diversi batteri gram-negativi. Secondo l'articolo di ricerca da loro pubblicato sulla rivista MDPI nel giugno 2021, gli antibiotici a base di carbapenemi come Meropenem ed Ertapenem sono stati i più efficaci contro i batteri gram-negativi, mostrando rispettivamente tassi di resistenza del 3% e del 5,4%. Questi antibiotici sono accettati a livello globale come trattamento per i batteri gram-negativi. Pertanto, si stima che l'elevata domanda di antibiotici a base di carbapenemi probabilmente continuerà nei prossimi anni.AMR) has become a global threat to modern medicine. Therefore, constant monitoring of emerging trends is required for the clinical isolates. A group of researchers in Latvia, Europe, has studied the progression of AMR for different gram-negative bacteria. As per the research article published by them in the MDPI journal in June 2021, carbapenem-based antibiotics such as Meropenem and Ertapenem were the most effective against gram-negative bacteria, showing 3% and 5.4% resistance rates, respectively. These antibiotics are globally accepted as a treatment for gram-negative bacteria. Therefore, it is estimated that the high demand for carbapenem-based antibiotics is likely to continue in the coming years.
Secondo i Centers for Disease Control and Prevention (CDC), la pandemia di COVID-19 ha portato all'aumento dei casi di HAI nel 2020. I ricoveri ospedalieri sono aumentati a livello globale, il che ha aumentato il rischio di VAP come infezione secondaria per i pazienti COVID-19. Ciò ha portato a una domanda alimentata di antibiotici a base di carbapenemi, il che sta aiutando notevolmente il mercato.HAI cases in 2020. Hospital admissions have grown globally, which has increased the risk of VAP as a secondary infection for COVID-19 patients. This has resulted in fueled demand for carbapenem-based antibiotics, which is aiding the market significantly.
Informazioni basate sul tipo
Il mercato degli antibiotici a base di carbapenemi, per tipo, è segmentato in meropenem, doripenem, imipenem, tebipenem e altri. Il segmento degli altri ha detenuto la quota maggiore del mercato degli antibiotici a base di carbapenemi nel 2021 e si prevede che registrerà il CAGR più elevato nel mercato durante il periodo di previsione. È probabile che i crescenti sviluppi per gli antibiotici a base di carbapenemi guidino la crescita del mercato in futuro.carbapenem-based antibiotics market, by type, is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest share of the carbapenem-based antibiotics market in 2021, and it is anticipated to register the highest CAGR in the market during the forecast period. The growing developments for carbapenem-based antibiotics are likely to drive the market growth in the future.
Approfondimenti basati sulle indicazioni
Per indicazione, il mercato degli antibiotici a base di carbapenemi è segmentato in meningite batterica, infezioni pelviche acute, infezioni del tratto respiratorio , infezioni intra-addominali, infezioni del tratto urinario e altri. Il segmento degli altri ha detenuto la quota maggiore del mercato degli antibiotici a base di carbapenemi nel 2021 e si stima che registrerà il CAGR più elevato nel mercato durante il periodo di previsione. L'incertezza delle infezioni batteriche spinge la domanda di antibiotici a base di carbapenemi, che dovrebbe guidare la crescita del mercato nei prossimi anni.carbapenem-based antibiotics market is segmented into bacterial meningitis, acute pelvic infections, intra-abdominal infections, carbapenem-based antibiotics market in 2021, and it is estimated to register the highest CAGR in the market during the forecast period. The uncertainty of bacterial infections propels the demand for carbapenem-based antibiotics, which is expected to drive the growth of market in the coming years.
Approfondimenti regionali sul mercato degli antibiotici a base di carbapenemi
Le tendenze regionali e i fattori che influenzano il mercato degli antibiotici a base di carbapenemi durante il periodo di previsione sono stati ampiamente spiegati dagli analisti di Insight Partners. Questa sezione discute anche i segmenti e la geografia del mercato degli antibiotici a base di carbapenemi in Nord America, Europa, Asia Pacifico, Medio Oriente e Africa e America meridionale e centrale.
- Ottieni i dati specifici regionali per il mercato degli antibiotici a base di carbapenemi
Ambito del rapporto di mercato sugli antibiotici a base di carbapenemi
| Attributo del report | Dettagli |
|---|---|
| Dimensioni del mercato nel 2021 | 3,96 miliardi di dollari USA |
| Dimensioni del mercato entro il 2028 | 5,35 miliardi di dollari USA |
| CAGR globale (2021 - 2028) | 4,4% |
| Dati storici | 2019-2020 |
| Periodo di previsione | 2022-2028 |
| Segmenti coperti | Per tipo
|
| Regioni e Paesi coperti | America del Nord
|
| Leader di mercato e profili aziendali chiave |
|
Densità degli attori del mercato degli antibiotici a base di carbapenemi: comprendere il suo impatto sulle dinamiche aziendali
Il mercato degli antibiotici a base di carbapenemi sta crescendo rapidamente, spinto dalla crescente domanda degli utenti finali dovuta a fattori quali l'evoluzione delle preferenze dei consumatori, i progressi tecnologici e una maggiore consapevolezza dei benefici del prodotto. Con l'aumento della domanda, le aziende stanno ampliando le loro offerte, innovando per soddisfare le esigenze dei consumatori e capitalizzando sulle tendenze emergenti, il che alimenta ulteriormente la crescita del mercato.
La densità degli operatori di mercato si riferisce alla distribuzione di aziende o società che operano in un particolare mercato o settore. Indica quanti concorrenti (operatori di mercato) sono presenti in un dato spazio di mercato in relazione alle sue dimensioni o al valore di mercato totale.
Le principali aziende che operano nel mercato degli antibiotici a base di carbapenemi sono:
- Pfizer Inc.
- Salvatore Lifetec
- Sumitomo Dainippon Pharma Co., Ltd.
- Merck & Co., Inc.
- Gland Pharma Limited
Disclaimer : le aziende elencate sopra non sono classificate secondo un ordine particolare.
- Ottieni una panoramica dei principali attori del mercato degli antibiotici a base di carbapenemi
Informazioni basate sui canali di distribuzione
In base al canale di distribuzione, il mercato degli antibiotici a base di carbapenemi è segmentato in farmacie al dettaglio, farmacie online e farmacie ospedaliere. Il segmento delle farmacie ospedaliere ha detenuto la quota maggiore del mercato degli antibiotici a base di carbapenemi nel 2021 e si stima che registrerà il CAGR più elevato nel mercato durante il periodo di previsione.
Le strategie organiche, come il lancio di nuovi prodotti, sono comunemente adottate dalle aziende per espandere i loro portafogli di prodotti sul mercato. Inoltre, le aziende hanno implementato varie strategie inorganiche, come fusioni e acquisizioni e partnership. Ad esempio, a maggio 2021, Gland Pharma Limited in associazione con Dr Reddy's Laboratories Ltd ha lanciato Ertapenem for Injection, 1 g/vial, un equivalente terapeutico della versione generica di INVANZ (ertapenem for injection) for injection) 1 g/vial, che è approvato dalla Food and Drug Administration (USFDA) degli Stati Uniti.
Profili aziendali
- Pfizer Inc.
- Salvatore Lifetec
- Sumitomo Dainippon Pharma Co., Ltd.
- Merck & Co., Inc.
- Gland Pharma Limited
- Aurobindo Pharma Ltd
- DAEWOONG FARMACEUTICA CO.,LTD
- Iterum Terapeutica plc
- ACS Dobfar SpA
- Spero Terapeutica
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Industrial Inkjet Printers Market
- Rare Neurological Disease Treatment Market
- Artwork Management Software Market
- Wheat Protein Market
- Fill Finish Manufacturing Market
- Sodium Bicarbonate Market
- Constipation Treatment Market
- Hair Wig Market
- Authentication and Brand Protection Market
- Surgical Gowns Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The carbapenem-based antibiotics market is analyzed in the basis of type, indication, and distribution channel. Based on type, is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest share of the market, and it is anticipated to register the highest CAGR. Based indication, the market is segmented as bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the market, and it is estimated to register the highest CAGR. And based on distribution channel, the market is divided into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the market, and it is estimated to register the highest CAGR.
The carbapenem-based antibiotics market majorly consists of the players such as Pfizer Inc.; Savior Lifetec; Sumitomo Dainippon Pharma Co., Ltd.; Merck & Co., Inc.; Gland Pharma Limited; Aurobindo Pharma Ltd; Daewoong Pharmaceutical Co.,Ltd; Iterum Therapeutics plc; ACS Dobfar S.p.A, and Spero Therapeutics among others.
Carbapenems are type of atypical β-lactam antibiotics that have wider antibacterial activity. Carbapenem-based antibiotics can cover many gram-positive, gram-negative aerobic, anaerobic bacteria. Additionally, carbapenem-based antibiotics are stable to most β-lactamases and hence, are indicated as empiric monotherapy for various serious conditions such as neutropenic infections and intra-abdominal infections.
The factors that are driving the growth of market are growing rising prevalence of gram-negative bacterial infections and increasing production of generic drugs fuel the growth of the market. However, the tedious and expensive process of antibiotic development, as well as approval, is the major factor hindering the market growth.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Carbapenem Based Antibiotics Market
- Pfizer Inc.
- Savior Lifetec
- Sumitomo Dainippon Pharma Co., Ltd.
- Merck & Co., Inc.
- Gland Pharma Limited
- Aurobindo Pharma Ltd
- Daewoong Pharmaceutical Co.,Ltd,
- Iterum Therapeutics plc
- ACS Dobfar S.p.A
- Spero Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For